Retraction Note: LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.

IF 3.4 2区医学 Q2 ONCOLOGY BMC Cancer Pub Date : 2025-01-14 DOI:10.1186/s12885-025-13492-7

Ziyi Zhao, Yingwei Sun, Jing Tang, Yuting Yang, Xiaochao Xu

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

注：LRPPRC调节骨肉瘤和衍生癌干细胞的恶性行为，保护线粒体稳态和线粒体功能。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

BMC Cancer 医学-肿瘤学

CiteScore

6.00

自引率

2.60%

发文量

1204

审稿时长

6.8 months

期刊介绍： BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

期刊最新文献

Exploring psychological distress, appraisal, and coping during the scan result journey: a qualitative study of young and middle-aged Chinese adults with advanced cancer. Sensitivity of different epidermal growth factor receptor (EGFR) exon 19 deletion subtypes to first-line osimertinib in Chinese non-small cell lung cancer patients. Dabrafenib or trametinib in pediatric Langerhans cell histiocytosis with bone lesions: a retrospective efficacy and safety study. Correction to: Factors associated with occurrence of drug therapy problems among patients with neoplasms of digestive organs at Uganda Cancer Institute, Mbarara: a cross-sectional study. The potential antitumor effects of combining intravesical therapy with recombinant bacillus calmette-guérin and an anti-PD-1 inhibitor in bladder cancer.